This webinar focuses on the baseline assessment of shortness of breath and the association with early or established interstitial lung disease.
Learning Objectives
Dr Vasilis Kouranos Background
Dr Vasilis Kouranos is highly specialised in pulmonary fibrosis and interstitial lung diseases such as idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and connective tissue disease-associated interstitial lung diseases at Royal Brompton Hospital.
He has sub-specialist expertise in sarcoidosis and particularly cardiac sarcoidosis, which was the subject of his PhD thesis. He also offers clinical support for sarcoidosis and ILD patients with lung cancer.
Professor Michael Polkey, Interim Director of Research and Care Group Chair for Lung Failure, Royal Brompton Hospital.
With the second longest commute in the NHS, Professor Poley works for 8 weeks per year in the NHS Highland where he provides respiratory services to Lochaber, Skye and Points West.
Professor Michael Polkey Background
Professor Michael Polkey is an academic and continues as a professor of respiratory medicine at Imperial College London.
He specialises in many respiratory conditions: chronic obstructive pulmonary disease (COPD), respiratory aspects of neurological disease, advanced lung disease, sleep disordered breathing, emphysema, diaphragm disease.
In particular, he specialises in the management of chronic respiratory failure, COPD, weaning patients from invasive mechanical ventilation. He is also an expert in neurological diseases as motor neurone disease (MND) known as amyotrophic lateral sclerosis (ALS) and Lou Gehrig’s disease.
Focusing on how to diagnose chronic cough in children and decide who needs investigations within primary care.
Dr Ian Balfou-Lynn Background
Dr Ian Balfour-Lynn is a consultant in paediatric respiratory medicine at Royal Brompton and Harefield hospitals.
Dr Ian Balfour-Lynn specialises in all aspects of paediatric respiratory medicine and performs all complex investigations including flexible bronchoscopy as a diagnostic tool. He is a specialist in severe infant wheezing, severe asthma, cystic fibrosis and recurrent chest infections.
Jens Spiesshoefer, MD, PhD, Assistant Professor (Privatdozent) of Respiratory Medicine and Binaya Regmi, MD: Jens graduated from medical school in 2016 with his MD thesis on sleep disordered breathing (group Professor Olaf Oldenburg) and completed a PhD program in translational medicine at Scuola Superiore Sant’ Anna Pisa from 2019-2022 (group Professor Alberto Giannoni).
Since 2021 and together with Binaya Regmi who defended his MD on diaphragm dysfunction in Long Covid in 2023 their now RWTH Aachen University Hospital (Department Prof Michael Dreher) based own labs and groups translational research focuses mainly on diaphragm dysfunction and its clinical consequences. This comprises invasive gold standard techniques to determine respiratory muscle activity as well as sympathetic nerve activity.
This talk will focus on the analysis of audit data and how and where clinical data gets used.Â
Learning Objectives:
This talk by Mr Espeed Khoshbin focuses on on managing post cardiac surgical patients in the primary care setting.
Focusing on the role of primary care physicians in managing post operative complications and secondary prevention after coronary artery bypass grafting (CABG), with reference to antiplatelet agents and lipid-lowering medications. Management of hypertension, diabetes mellitus, smoking cessation, weight loss, and cardiac rehabilitation.
Learning Objectives
Mr Espeed Khoshbin Background
Mr Espeed Khoshbin is a consultant in cardiac surgery transplantation and mechanical circulatory support at Royal Brompton and Harefield hospitals. He is also an honorary clinical senior lecturer at Imperial College and The National Heart and Lung Institute (NHLI) in London. He is the national lead for heart and lung transplant education, local lead for cardiac surgical training and an examiner for the board of examiners of the European and UK cardiac surgery.Mr Khoshbin is the NHS lead for organ utilisation at Royal Brompton and Harefield Hospitals.
This talk by professor Mona Bafadhel focuses on eosinophilis in COPD as a major healthcare burden and cause of mortality worldwide.
Learning Objectives
Professor Mona Bafadhel Background
Mona Bafadhel holds the positions of Chair in Respiratory Medicine at King’s College London and Director of the recently established King’s Centre for Lung Health. Additionally, she works as a consultant respiratory physician at the Guy’s and St. Thomas’ NHS Foundation Trust. Her areas of interest in both clinical and research are asthma and chronic obstructive pulmonary disease (COPD). With a strong desire to use clinical research to better patient outcomes, Mona is a leading international academic in the field of respiratory medicine. Her research on COVID-19 and COPD has changed therapeutic practices that impact millions of people worldwide. The Royal College of Physicians bestowed to Mona the Goulstonian Lectureship in 2018 in recognition of her achievements in the clinical sciences. She is the first woman from an ethnic minority and just the fourth overall.
This talks by Professor Nicholas Hopkinson covers COPD as a structural violence.
Professor Nicholas Hopkinson background
Nicholas Hopkinson is professor of respiratory medicine at Imperial College and an honorary consultant physician at Royal Brompton Hospital. He qualified in medicine at Cambridge University and the London Hospital Medical College and went on to train in respiratory and general internal medicine at St George’s Hospital and St Thomas’ Hospital.
Professor Hopkinson is clinical lead for chronic obstructive pulmonary disease (COPD) at Royal Brompton Hospital. This includes systematic evaluation of patients within a multidisciplinary team and addressing issues such as: hypoxia, recurrent exacerbations, alpha one antitrypsin deficiency, early onset disease.
His major research interest looks at the causes of exercise limitation in patients with COPD, and his publications have looked at the: effect of pulmonary rehabilitation, influence of genetic polymorphisms, the effect of dietary nitrate supplementation, lung volume reduction techniques for emphysema, singing for lung health as an approach to relieve breathlessness in COPD and other conditions.
Working with the NW London Collaboration for Leadership in Applied Health Research (CLAHRC), Professor Hopkinson has developed a more systematic Care Bundle for COPD patients as they are discharged. Addittionally, he has published work on tobacco uptake among children and in support of tobacco control measures, such as standardised packaging and smoke-free legislation.
Moreover, the NIHR, Medical Research Council, Wellcome Trust, European Union, British Lung Foundation, and Moulton Foundation have all funded professor Hopkinson’s work.
This talk by Dr Rigby covers the significance of chest pain in children and adolescents.
Dr Rigby explains how chest pain is common in children and adolescent ages 8 to 18. This leads to the importance of aetiology which is often evident when taking a detailed history of the patient.
The talk explains the most common type of chest pain and next steps to take when dealing with patients with those symptoms.
Dr Michael Rigby Background
Dr Michael Rigby is a consultant paediatric cardiologist at Royal Brompton Hospital, specialising in interventional cardiac catheterisation in congenital heart disease in children and young adults.
Prior to this role, Dr Rigby trained at the Killingbeck Hospital in Leeds, the Birmingham Children’s Hospital, John Radcliffe Hospital in Oxford and the Hospital for Sick Children in Toronto, Canada.
This talk by Dr Jamilah Meghji covers “the intersection of TB and Chronic Lung Diseases in LMIC”
Dr Jamilah Meghji BackgroundÂ
Dr Jamilah Meghji is a Consultant Respiratory Physician in Cambridge, UK, with a special interest in tuberculosis and respiratory infection. Her research has used mixed methods to describe the burden and impact of post-TB lung disease on the lives and livelihoods of TB survivors in East Africa. She has an interest in the diagnosis and management of TB co-morbidities, including chronic respiratory diseases, within TB services in low-resource settings.
This talk by Dr James Allinson provides an overview of how early childhood respiratory infections are linked to adult respiratory disease.
Dr James Allinston BackgroundÂ
Dr Allinson is a consultant respiratory physician at Royal Brompton Hospital, working in the fields of chronic obstructive pulmonary disease (COPD) and respiratory failure.
Dr Allinson graduated in 2002 from St Peter’s College, University of Oxford and completed his postgraduate training at Oriel College, University of Oxford, in 2005. He trained in respiratory and general medicine in London and was awarded a PhD from Imperial College London in 2018.
Dr Allinson’s research interests include how airways disease develops across life and how to identify the early stages of COPD development. His research also addresses how to improve the management of already established COPD. Dr Allinson is the primary investigator on an Asthma + Lung UK Project Grant.
This talk by Parris William focuses on “why we need to embed smoking cessation services into targeted lung health checks”.
This talk by Dr Dexter J Wiseman covers “RSV as a Cause of COPD Exacerbation and Beyond: The Hidden Annual Epidemic“.
Dr Dexter Wiseman Background
Dr Dexter Wiseman has an honorary positions at the Royal Brompton and Harefield NHS trust and the National Heart and Lung Institute as clinical research fellows and senior practitioners, respectively.
Dexter is now working at Professor Jadwiga ‘Wisia’ Wedzicha’s lab as part of his research study. In the past, he assisted in managing the London COPD exacerbation cohort. His research interests include the role of viruses in COPD flare-ups. In order to complete his PhD, he examined the part that RSV (Respiratory Syncytial Virus) plays both during flare-ups and times of stability.
In order to better understand the immunological indicators of RSV susceptibility in COPD patients, Dexter collaborates closely with Professor Peter Openshaw and Dr. Ryan Thwaites through the international partnership RESCEU (Respiratory Syncytial virus partnership in Europe).